health
Rafah Crossing Reopens With Only Limited Movement on First Day
By The Media Line Staff
Despite the landmark opening on Monday of the Rafah Crossing, which had been closed during the two years of war between Israel and Hamas, fewer than the expected number of people were reported to have passed either to or...
Read More
Health Rounds: Apple watches help patients monitor a common heart disorder
By Nancy Lapid
Jan 30 (Reuters) – Apple watches are proving useful in screening for the common heart rhythm disorder atrial fibrillation, or AFib, according to two studies published in the Journal of the American College of Cardiology.
AFib, which significantly raises the...
Read More
Novo’s Wegovy pill surpasses 26,000 prescriptions in second full week
Jan 30 (Reuters) – Novo Nordisk’s Wegovy pill hit over 26,000 U.S. prescriptions in the second full week after its launch, IQVIA data shared by an analyst on Friday showed.
Investors are closely watching prescription data to see if the Danish drugmaker can press its...
Read More
health Headlines
- McKesson boosts 2026 profit forecast amid specialty drug growth
- Autism might be equally common in males and females, study says
Regional health organization issues alert as measles cases surge across the Americas- After 80 years, Minute Maid’s frozen canned juices are getting put on ice
- Align Technology beats fourth-quarter results estimates on dental products demand
- Plastic surgeons group calls for delaying gender-affirming surgery until age 19
- Experimental cholesterol-lowering pill may offer new option for millions
- Insurer MetLife adjusted quarterly profit rises on strong investment returns
- South Carolina measles vaccinations jump in January, fueled by surge in Spartanburg County
- Dental sector may steady in 2026, but full recovery remains distant, analysts say
- Novo to launch Ozempic pill for diabetes in second quarter of 2026
- WHO announces restart of preventive cholera vaccinations after nearly 4-year halt
- PAHO calls for increased surveillance amid rising measles cases in the Americas
- Cigna settles FTC insulin case, aims to lower drug prices
- US FDA says injuries from Abbott’s recalled glucose sensors reach 860
- Analysis-Novo Nordisk risks weight-loss price war as discount pressures deepen
- Backyard vegetable gardens are healthy for people and the planet. Here’s how to start yours
- Novo Nordisk plunge wipes $50 billion off obesity drug giant
- Biotech firm PrimeGen to go public in $1.5 billion SPAC deal
- Boston Scientific shares fall as key segment’s performance spooks investors
- AbbVie forecasts 2026 profit above estimates on strong sales of newer immunology drugs
- GE HealthCare forecasts 2026 profit above estimates on strong demand for medical devices
- Lilly sees strong growth in 2026 as weight-loss drug rival Novo slips
- Nestle widens infant formula recall after EU requests new toxin analysis
- Novo Nordisk sees ‘painful’ US price cuts for Wegovy as investment in the future
- Wegovy-maker Novo Nordisk warns ‘unprecedented’ price pressure to hit sales
- Novartis flags 2026 profit drop as patents for key drugs expire
- Illinois will join WHO’s outbreak response network in defiance of Trump
- Lindsey Vonn’s decision to compete with a torn ACL is risky but ‘possible,’ experts say
- Lawyers for patients of UCLA doctor say clients shaken by court overturning his sex abuse conviction
- Amgen Q4 results beat Street estimates, company says patients need weight-loss options
- Kaiser readies for pharmacy, lab worker strike as nurse walkout continues
- US plastic surgeons group advises delaying gender surgery until age 19 due to insufficient evidence
- Obesity stocks slump on Novo’s underwhelming 2026 sales forecast
- House lawmaker raises new concerns over FDA’s ultra-fast drug review program
- Measles cases in South Carolina rise by 29 to 876, state health department says
- The Media Line: Ben-Gurion University Study Finds Skin Gene Also Powers the Body’s Frontline Immune Defense
- Wegovy maker Novo Nordisk appoints Jamey Millar head of its US business
- Novo Nordisk warns on profits and sales amid Trump drug price crackdown
- Longevity expert Dr. Peter Attia steps down from David Protein after Epstein links
- How to create a calming ‘nature nook’ with indoor plants. Advice from Hilton Carter
- Medical device maker Medtronic to buy CathWorks in up to $585 million deal
- Pfizer weight-loss drug data raises questions about side effects, shares fall
- Pfizer’s experimental drug shows up to 12.3% weight loss in mid-stage trial
- WHO cuts appeal for health emergencies by a third to $1bln in 2026
- Why China is building so many coal plants despite its solar and wind boom
- US FDA rejects AstraZeneca’s easier-to-use version of lupus therapy
- Sleep device maker ResMed ramps up doctor outreach to tap Ozempic surge
- MAHA has reshaped health policy. Now it’s working on environmental rules
- In the face of aid cuts, Gates Foundation narrows its priorities and defends global health funding
